About this trial
The purpose of this study is to assess the prognostic value of absolute value and kinetic of neurofilament light chain (NFL) collected at different time points (at admission, 12h, 24h, 48h, 72h, 96h, and day 7 after ICU admission) in predicting poor and good neurological outcome in comatose patients after cardiac arrest.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the ICU for cardiac arrest,
Patients who regained consciousness following in-hospital or out-of-hospital cardiac arrest,
Patients in a coma upon arrival in the ICU, defined by a Glasgow Coma Scale (GCS) score <8,
Patients included in the AfterROSC2 cohort,
Disqualifiers
Terminally ill patients (death expected within 3 hours of admission to the ICU),
Minors,
Patients under legal guardianship,
Pregnant women,
Trial population
Comatose patients after cardiac arrest
Trial design
Cohort
Prospective
Treatments tested in this trial
Value of neurofilament light chain (NFL) at different time points
Other interventionValue of neurofilament light chain (NFL) at different time points (H0, H12, H24, H48, H72, H96, and day 7 after ICU admission
Treatment groups
Trial outcomes
Primary outcomes
modified Rankin Scale (mRS)
Neurological outcome assessed by the modified Rankin Scale (mRS) (An unfavorable outcome is defined as a modified Rankin Scale (mRS) score between 4 and 6 (severe neurological sequelae, persistent coma, or death), and a favorable outcome as a modified Rankin Scale (mRS) score between 0 and 3 (no sequelae, mild to moderate neurological sequelae))
Secondary outcomes
Mortality
Early myoclonus
Clinical, imaging, or neurophysiological neurological abnormalities : early myoclonus (\<72 hours)
Myoclonus status
Clinical, imaging, or neurophysiological neurological abnormalities: myoclonus status (\<72 hours post-CA)
Pupillary and corneal reflexes
Clinical, imaging, or neurophysiological neurological abnormalities: pupillary and corneal reflexes at 72 hours post-CA
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: